一种抗菌多肽及应用

本发明公开了一种抗菌多肽及应用。其来源于新型冠状病毒(SARS‑CoV‑2)的Replicase polyprotein 1a蛋白,其氨基酸序列如SEQ ID No.01或SEQ ID No.03所示。本发明的抗菌多肽对金葡菌等革兰阳性菌和大肠杆菌、肺炎克雷伯菌、鲍曼不动杆菌等常见的临床致病菌具有较强的抗菌活性,对多种多药耐药菌具有较强的抗菌活性,如耐甲氧西林的金葡菌、耐碳青霉烯的大肠杆菌、耐碳青霉烯的肺炎克雷伯菌均对其敏感,特别是耐碳青霉烯的鲍曼不动杆菌对Cov6多肽的MIC低至4μM;本发明抗菌多肽还具有溶血及细胞毒性极低的优点,具备作为药物和食品添加剂开发的条件,具有广泛的应用前景。.

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 12. März Zur Gesamtaufnahme - year:2024

Sprache:

Chinesisch

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A01N: Preservation of bodies of humans or animals or plan (...)
A01P: Biocidal, pest repellant, pest attractant or plant (...)
A23K: Feeding-stuffs specially adapted for animals; metho (...)
A23L: Foods, foodstuffs, or non-alcoholic beverages, not (...)
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
A61Q: Specific use of cosmetics or similar toilet prepara (...)
bio
C11D: Detergent compositions; use of single substances as (...)
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
cet
che
hor

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-12, Last update posted on www.tib.eu: 2024-03-27, Last updated: 2024-03-29

Patentnummer:

CN117004590

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA001517902